Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis
-
Published:2023-10
Issue:10
Volume:11
Page:3047-3054
-
ISSN:2213-2198
-
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
-
language:en
-
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice
Author:
Tal Yuval,
Ribak Yaarit,
Rubin Limor,
Talmon Aviv,
Shamriz OdedORCID,
Hershko Alon Y.,
Blotnick Simcha,
Bouhajib Mohammed,
Krayz Galia Temtsin,
Abrutzky Carolina,
Megiddo Dalia,
Lapidot TairORCID,
Caraco Yoseph
Subject
Immunology and Allergy
Reference35 articles.
1. Fatal anaphylaxis: mortality rate and risk factors;Turner;J Allergy Clin Immunol Pract,2017
2. The pathophysiology of anaphylaxis;Reber;J Allergy Clin Immunol,2017
3. World Allergy Organization anaphylaxis guidance 2020;Cardona;World Allergy Organ J,2020
4. Addressing common misconceptions in food allergy: a review;Anagnostou;Children (Basel),2021
5. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities;Prince;J Asthma Allergy,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献